Pharmacotherapy

Papers
(The TQCC of Pharmacotherapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review106
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect102
Warfarin dosage in a postpartum woman while breastfeeding: A case report76
Update and narrative review of avian influenza (H5N1) infection in adult patients62
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps56
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy49
42
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey40
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy39
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial35
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors35
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation34
31
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”31
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant30
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy30
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)29
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency27
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution27
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures27
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy27
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse26
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy22
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”22
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study22
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care22
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn21
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation21
Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam21
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations20
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 19
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial19
17
Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study17
Issue Information17
17
Approaches to Precision‐based Anticoagulation management in the critically Ill17
Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Ac17
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application16
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents16
Issue Information15
15
Impact of dexmedetomidine in conjunction with a weaning protocol on post‐surgical opioid use in a neonatal intensive care unit15
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”14
Issue Information14
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries14
Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study13
Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study13
Issue Information13
13
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk13
Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy13
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections13
Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders13
The role of inflammation in the pathogenesis and treatment of arrhythmias12
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain12
Issue Information12
12
Efficacy and safety of factor Xa inhibitors in low body weight patients12
Issue Information12
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy12
Critique of “Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”12
12
Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases12
11
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study11
Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature11
Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study10
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults10
Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications10
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort10
Issue Information10
Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis10
Issue Information10
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review9
Standards of practice to advance the quality of health care9
Comment on “The power and pitfalls of underpowered studies”9
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers9
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids9
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection9
Current clinical pharmacology issues in pregnancy and pediatrics9
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients9
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study9
Myocardial infarction associated with erenumab: A case report9
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis9
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring9
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone8
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation8
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report8
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report8
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction8
Correction to “Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis”8
Serum potassium response to single‐dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients8
Emerging therapies for eosinophilic esophagitis8
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction8
Precision‐based approaches to delirium in critical illness: A narrative review8
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”8
Comment on “Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy”7
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimi7
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review7
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics7
The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics7
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients7
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease7
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors7
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population7
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan7
Issue Information7
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens7
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis7
Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics7
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society6
Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy6
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion6
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial6
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase prod6
In Search of Big Beautiful Biomarkers6
Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service6
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis6
6
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota6
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia6
Clinical outcomes associated with anti‐Xa‐monitored enoxaparin for venous thromboembolism prophylaxis6
Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections 6
6
0.12316298484802